CLF-funded researcher Dr. John Ussher is studying how a heart disease treatment called ranolazine can reduce the severity of non-alcoholic fatty liver disease (NAFLD). This exciting study can result in finding a successful treatment for NAFLD.
Our conversation with Dr. Amanda Ricciuto, a clinical research fellow at the Hospital for Sick Children, exemplifies the female role-models that make up our leadership, our funded researchers, our volunteers and more.
Debbie was living unaware that her liver was in deep trouble due to non-alcoholic fatty liver disease, the largest liver disease in Canada.
We put a lot of effort into showing the special people in our lives how truly loved they are on Valentine’s Day. But, do we do enough to show our liver how much we care about it?